TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Heron Therapeutics Inc (NASDAQ:HRTX) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If youpurchased shares of Heron Therapeutics Inc (NASDAQ:HRTX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Heron Therapeutics Inc
Security
NASDAQ: HRTX

Summary

April 27, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Heron Therapeutics Inc (NASDAQ:HRTX) was announced over potential breaches of fiduciary duties by certain officers and directors at Heron Therapeutics.

The investigation by a law firm concerns whether certain Heron Therapeutics officers and directors breached their fiduciary duties.

Shares of Heron Therapeutics Inc (NASDAQ:HRTX) declined from $40.81 per share in late September 2015 to as low as $15.22 per share in March 2016.

Start Monitoring Your Investments